Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94338012 | 9433801 | 2 | F | 20121216 | 20160825 | 20130731 | 20160901 | EXP | PHEH2012US025007 | NOVARTIS | 28.61 | YR | M | Y | 122.45000 | KG | 20160901 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 94338012 | 9433801 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 5 MG, QD | 22334 | 5 | MG | TABLET | QD | ||||||
| 94338012 | 9433801 | 2 | SS | AFINITOR | EVEROLIMUS | 1 | Oral | 7.5 MG, QD | 22334 | 7.5 | MG | TABLET | QD | ||||||
| 94338012 | 9433801 | 3 | SS | AFINITOR | EVEROLIMUS | 1 | Unknown | UNK | 22334 | TABLET | |||||||||
| 94338012 | 9433801 | 4 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 40 MG | Y | 0 | 40 | MG | TABLET | ||||||
| 94338012 | 9433801 | 5 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 20 MG, QD | Y | 0 | 20 | MG | TABLET | QD | |||||
| 94338012 | 9433801 | 6 | C | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | 5 MG, QD | U | 0 | 5 | MG | TABLET | QD | |||||
| 94338012 | 9433801 | 7 | C | TEGRETOL | CARBAMAZEPINE | 1 | Unknown | 400 MG, BID | U | 0 | 400 | MG | EXTENDED RELEASE TABLET | BID | |||||
| 94338012 | 9433801 | 8 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 94338012 | 9433801 | 9 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 94338012 | 9433801 | 1 | Angiomyolipoma |
| 94338012 | 9433801 | 4 | Product used for unknown indication |
| 94338012 | 9433801 | 6 | Product used for unknown indication |
| 94338012 | 9433801 | 7 | Product used for unknown indication |
| 94338012 | 9433801 | 8 | Sleep disorder |
| 94338012 | 9433801 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 94338012 | 9433801 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 94338012 | 9433801 | Dysuria | |
| 94338012 | 9433801 | Feeling cold | |
| 94338012 | 9433801 | Headache | |
| 94338012 | 9433801 | Hypersensitivity | |
| 94338012 | 9433801 | Malaise | |
| 94338012 | 9433801 | Nausea | |
| 94338012 | 9433801 | Nephrolithiasis | |
| 94338012 | 9433801 | Oral pain | |
| 94338012 | 9433801 | Oropharyngeal pain | |
| 94338012 | 9433801 | Pain | |
| 94338012 | 9433801 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 94338012 | 9433801 | 1 | 20121129 | 0 | ||
| 94338012 | 9433801 | 2 | 20130515 | 0 | ||
| 94338012 | 9433801 | 3 | 20160811 | 0 |